PWM
AGIO icon

PRW Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

PRW Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-33
Closed -$2K – 79
2019
Q1 		$2K Hold
33
– – ﹤0.01% 491
2018
Q4 		$2K Buy
+33
New +$2.04K ﹤0.01% 490

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PRW Wealth Management's AGIO Position: Q2 2019 in Review

PRW Wealth Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 33 shares — an estimated $2K sold.

PRW Wealth Management first reported a position in AGIO in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • PRW Wealth Management reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • PRW Wealth Management sold 33 Agios Pharmaceuticals shares in Q2 2019, an estimated $2K.
  • PRW Wealth Management first reported a position in Agios Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • PRW Wealth Management's Agios Pharmaceuticals position peaked at $2K in Q1 2019.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on PRW Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.